Pacira Pharma (PCRX): EXPAREL Sales Are Tracking Below Consensus - Wedbush

September 21, 2016 8:16 AM EDT Send to a Friend
Wedbush analyst, Liana Moussatos, reiterated her Outperform rating on shares of Pacira Pharmaceuticals (NASDAQ: PCRX) while noting that the Symphony ...

To continue reading this article and more like it please sign-in or join today (FREE!)

Member Login